Cryocompression With or Without Cilostazol for Paclitaxel-Induced Neuropathy
Phase 2
70
about 3.4 years
18+
Female only
3 sites in GA
What this study is about
This trial is testing whether cryocompression therapy, alone or with cilostazol, can help prevent peripheral neuropathy caused by paclitaxel in women with gynecological cancers. Peripheral neuropathy is a common side effect of paclitaxel, which stops cancer cells from growing and dividing. Cryocompression combines compression garments with cooling to improve blood flow.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Best Practice
- 2.Quality-of-Life Assessment
- 3.Take Cilostazol
- +2 more
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You are randomly assigned, but you will know your treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
cilostazol, paclitaxel (Taxane chemotherapy; stabilizes microtubules)
oral (Oral Tablet), injection, intravenous
Secondary: Rate of grade 3 adverse events
Oncology